Retinal layer thickness in preclinical Alzheimer's disease

PURPOSE: There is urgent need for non‐invasive diagnostic biomarkers in the preclinical phase of Alzheimer's Disease (AD). Several studies suggest that retinal thickness is reduced in AD. Here, we aim to test the diagnostic value of retinal thickness in preclinical AD, as defined by cognitively...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Kreeke, Jacoba A., Nguyen, Hoang‐Ton, den Haan, Jurre, Konijnenberg, Elles, Tomassen, Jori, den Braber, Anouk, ten Kate, Mara, Collij, Lyduine, Yaqub, Maqsood, van Berckel, Bart, Lammertsma, Adriaan A., Boomsma, Dorret I., Tan, Hendra Stevie, Verbraak, Frank D., Visser, Pieter Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900176/
https://www.ncbi.nlm.nih.gov/pubmed/31058465
http://dx.doi.org/10.1111/aos.14121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900176/
https://www.ncbi.nlm.nih.gov/pubmed/31058465
http://dx.doi.org/10.1111/aos.14121

Ejemplares similares